Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis 2002 Mar;8(3):320-3

Date

04/03/2002

Pubmed ID

11927032

Pubmed Central ID

PMC2732464

DOI

10.3201/eid0803.010249

Scopus ID

2-s2.0-0036196045 (requires institutional sign-in at Scopus site)   50 Citations

Abstract

We describe a case of human ehrlichiosis in a lung transplant recipient and review published reports on ehrlichiosis in immunocompromised patients. Despite early therapy with doxycycline, our patient had unusually severe illness with features of thrombotic thrombocytopenic purpura. Of 23 reported cases of ehrlichiosis in immunocompromised patients, organ failure occurred in all patients and 6 (25%) died.

Author List

Safdar N, Love RB, Maki DG



MESH terms used to index this publication - Major topics in bold

Adult
Anti-Bacterial Agents
Doxycycline
Ehrlichia chaffeensis
Ehrlichiosis
Humans
Lung Transplantation
Male
Postoperative Complications